OBI Pharma Receives ‘Most Promising ADC Clinical Candidate in Taiwan’ Award
Dr. Heidi Wang Accepts Award on Behalf of OBI Pharma at ADC Asia Congress 2025 and Gives a PresentationTAIPEI, Taiwan, March ...
EQS-News: Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
Ladenburg, Germany, 13 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company developing innovative Antibody Drug Conjugates (ADCs), and HealthCare Royalty (HCRx) today ...
ETF Daily News3d
ADC Therapeutics SA (NYSE:ADCT) Shares Acquired by Rhumbline Advisers
Rhumbline Advisers lifted its holdings in ADC Therapeutics SA (NYSE:ADCT – Free Report) by 15.6% in the 4th quarter, according to the company in its most recent disclosure with the SEC.
The Pharma Letter15h
SOTIO takes up option on Synaffix ADCs
Prague headquartered clinical-stage firm SOTIO Biotech, which is owned by the Czech Republic's PPF Group, today announced it ...
Contract Pharma9d
Axplora Launches Payload Manufacturing Workshop in France
Axplora, an API small molecule and ADC manufacturer, has launched a payload manufacturing workshop at its Le Mans site in ...
Fierce Pharma8d
After peptide expansion, Axplora hits the gas to boost ADC capacity at French facility
Less than a month after unveiling a peptide expansion at its production site in Mourenx, CDMO Axplora has hit the gas on a ...
Contract Pharma10d
Veranova Moves Headquarters to Devens, MA
Veranova has moved its corporate headquarters to its Devens, Massachusetts site, one of its principal sites for manufacturing ...
EQS-Adhoc: Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
Ladenburg, Germany, 12 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company developing innovative Antibody Drug Conjugates (ADCs), and HealthCare Royalty (HCRx) today ...